M9140 clinical trials
M9140 is named as an intervention in 3 current clinical trials in our USA, China, Spain, Japan, South Korea, Germany, France, Italy, Austria, Australia and Canada registers. None are recruiting at the moment. The most common phase is Phase 1. The sponsor with the most trials is EMD Serono Research & Development Institute, Inc (2). The most-studied condition is Solid Tumors.
Patient leaflets for M9140
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Trials by status
Trials by phase
Clinical trials of M9140
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)
NCT06710132 · Solid Tumors, Gastric Cancer, Non-Small Cell Lung Cancer (NSCLC)
|
Phase 1/2 | Active, closed | EMD Serono Research & Development Institute, Inc | USA, China, Germany, France, Spain, Italy, Austria, Japan, South Korea, Australia |
|
Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01)
NCT05464030 · Colorectal Cancer
|
Phase 1 | Active, closed | EMD Serono Research & Development Institute, Inc | USA, Spain, Canada, Japan, South Korea |
|
Anti-CEACAM5 ADC Precemtabart Tocentecan (M9140) in Chinese Participants With Solid Tumors
NCT06806046 · ClinicalTrials.gov ↗ · Solid Tumors, Colorectal Cancer
|
Phase 1 | Active, closed | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with M9140
5 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| EMD Serono Research & Development Institute, Inc | 2 |
| Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 1 |
By country register
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about M9140 trials
How many clinical trials are testing M9140?
3 current trials in our USA, China, Spain, Japan, South Korea, Germany, France, Italy, Austria, Australia and Canada registers name M9140 as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are M9140 trials recruiting patients?
Not at the moment. None of the 3 trials in our registers is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Who sponsors M9140 clinical trials?
EMD Serono Research & Development Institute, Inc (2) and Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how M9140 works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how M9140 works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists M9140 (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.